Thomas W. Jarrett, MD, presented “​Life Expectancy as It Relates to the Treatment of Urologic Cancers” during the 43rd Annual Ralph E. Hopkins Urology Seminar on January 31, 2024, in Jackson Hole, Wyoming.

This content is available free to the GRU Community. Login or create an account to view it.

Login

Create an Account

How to cite: Jarrett, Thomas W. “Life Expectancy as It Relates to the Treatment of Urologic Cancers.” January 31, 2024. Accessed Dec 2024. https://grandroundsinurology.com/life-expectancy-as-it-relates-to-the-treatment-of-urologic-cancers/

Life Expectancy as It Relates to the Treatment of Urologic Cancers – Summary

Thomas W. Jarrett, MD, discusses the impact of life expectancy on urologic cancer treatment and management in the United States. He begins by highlighting outdated life expectancy models and the importance of assessing life expectancy prior to exploring treatment options.

Dr. Jarrett then discusses the traditional methods of assessing life expectancy and their failure to account for patient comorbidities. He lists the most significant comorbidities which impact life expectancy according to their hazard score.

Dr. Jarrett then addresses overall trends in life expectancy in the United States. He notes that life expectancy sharply decreased during COVID-19 and that the United States has yet to recover compared to European life expectancy trends.

Dr. Jarrett concludes by illustrating the influence of perceived life expectancy on urologic cancer management and outcomes. He discusses the impact of life expectancy on treatment options for urothelial cancer, testicular cancer, renal cancer, and prostate cancer.

 

About The 43rd Annual Ralph E. Hopkins Urology Seminar:

The Ralph E. Hopkins Urology Seminar is a multi-day meeting focused on training urologists in the latest in assessing, diagnosing, and treating urologic conditions in the clinical setting. Updates are provided on urologic cancers, stone disease, urologic reconstruction, female urology, infertility, sexual function, emerging surgical techniques, and general urology. The 43rd iteration of the meeting took place from January 31st to February 2nd, 2024, in Jackson Hole, Wyoming.

For further educational activities from this conference, visit our collection page.

ABOUT THE AUTHOR

+ posts

Dr. Thomas W. Jarrett, Chief of Urology, National Capital Region, at the Brady Urological Institute and Department of Urology at Johns Hopkins School of Medicine, has an expertise in minimally invasive surgery, including laparoscopic, robotic, ureteroscopic, percutaneous and image-guided therapies. Specifically, he has an expertise in percutaneous renal surgery, laparoscopic partial and radical nephrectomy, kidney stones, urinary tract reconstruction and kidney cancer.